Guided Therapeutics, Inc.

0.2300+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCQB · GTHP · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
18.47M
P/E (TTM)
-
Basic EPS (TTM)
-0.05
Dividend Yield
0%

Recent Filings

About

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.

CEO
Dr. Mark L. Faupel Ph.D.
IPO
1/8/2021
Employees
4
Sector
Healthcare
Industry
Medical Devices